Alamar Biosciences, Inc. (ALMR) shareholders
Close on Nov 17, 2026Market cap $2.13BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Qiming Corporate GP VI, Ltd Joint filing with Qiming Venture Partners VI, L.P. (9.90%) | 7,066,573 | 10.20% | 13G (passive) | Jun 30, 2026 |
| Nicholas Naclerio Joint filing with Illumina Innovation Fund II GP, L.L.C. (8.80%), Illumina Innovation Fund II, L.P. (8.80%) | 6,363,612 | 9.60% | 13D (active) | Apr 20, 2026 |
| Daqing Cai Joint filing with Sherpa Healthcare Fund Ii, L.P. (5.70%), Sherpa Healthcare Fund II GP, Ltd. (5.70%) | 4,972,134 | 7.20% | 13G (passive) | Apr 16, 2026 |
| Yuling Luo | 4,528,718 | 6.40% | 13G (passive) | Jun 30, 2026 |
| Sands Capital Alternatives, LLC Joint filing with Sands Capital Life Sciences Pulse Fund II, L.P. (6.30%), Sands Frank M. (6.30%) | 4,230,926 | 6.30% | 13D (active) | Apr 16, 2026 |
| Sands Frank M. Joint filing with Sands Capital Life Sciences Pulse Fund II, L.P. (6.10%), Sands Capital Alternatives, LLC (6.10%) | 4,230,926 | 6.10% | 13D (active) amendment | Jul 5, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ALMR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Sands Capital Ventures, LLC | 4,230,926 | 6.10% | $114.62M | New | 18.68% |
| Samsara BioCapital, LLC | 2,480,310 | 3.57% | $67.19M | New | 5.52% |
| T. Rowe Price Investment Management, Inc. | 2,202,597 | 3.17% | $59.67M | New | 0.04% |
| ARK Investment Management LLC | 1,373,959 | 1.98% | $37.22M | New | 0.24% |
| Braidwell LP | 1,083,983 | 1.56% | $29.37M | New | 1.09% |
| Alliancebernstein L.P. | 1,003,077 | 1.45% | $27.17M | New | 0.01% |
| Hhlr Advisors, Ltd. | 956,462 | 1.38% | $25.91M | New | 3.11% |
| BlackRock, Inc. | 911,445 | 1.31% | $24.69M | New | 0.00% |
| Millennium Management LLC | 865,764 | 1.25% | $23.45M | New | 0.01% |
| FMR LLC | 829,424 | 1.20% | $22.47M | New | 0.00% |
| Pura Vida Investments, LLC | 755,909 | 1.09% | $20.48M | New | 123.99% |
| Emerald Advisers, LLC | 647,183 | 0.93% | $17.53M | New | 0.41% |
| Artisan Partners Limited Partnership | 613,744 | 0.88% | $16.63M | New | 0.03% |
| Deerfield Management Company, L.P. (Series C) | 600,000 | 0.86% | $16.25M | New | 0.17% |
| Vanguard Capital Management LLC | 463,385 | 0.67% | $12.55M | New | 0.00% |
| Farallon Capital Management LLC | 462,900 | 0.67% | $12.54M | New | 0.06% |
| Wellington Management Group Llp | 457,974 | 0.66% | $12.41M | New | 0.00% |
| Emerald Mutual Fund Advisers Trust | 422,127 | 0.61% | $11.44M | New | 0.40% |
| Ameriprise Financial Inc | 418,965 | 0.60% | $11.35M | New | 0.00% |
| Geode Capital Management, LLC | 330,134 | 0.48% | $8.95M | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 86 | 24M | 35.1% | 86 / 0 | 0 / 0 | 24M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ALMR | Value | % of fund | As of |
|---|---|---|---|---|---|
| ARK Genomic Revolution ETF | 957,178 | 1.38% | $24.27M | 1.56% | Jul 31, 2026 |
| AB Small Cap Growth Portfolio | 445,297 | 0.64% | $12.06M | 0.39% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 355,864 | 0.51% | $9.64M | 0.10% | Jun 30, 2026 |
| Columbia Small Cap Growth Fund | 345,768 | 0.50% | $7.07M | 0.19% | May 31, 2026 |
| iShares Russell 2000 ETF | 321,505 | 0.46% | $8.71M | 0.01% | Jun 30, 2026 |
| SmallCap Growth Fund I | 321,124 | 0.46% | $8.14M | 0.33% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 320,260 | 0.46% | $8.68M | 0.00% | Jun 30, 2026 |
| Select Health Care Portfolio | 300,000 | 0.43% | $6.13M | 0.11% | May 31, 2026 |
| Emerald Growth Fund | 280,435 | 0.40% | $7.11M | 0.48% | Jul 31, 2026 |
| Select Medical Technology and Devices Portfolio | 280,000 | 0.40% | $5.72M | 0.19% | May 31, 2026 |
| Artisan Small Cap Fund | 193,237 | 0.28% | $5.23M | 0.55% | Jun 30, 2026 |
| T. Rowe Price Institutional Small-Cap Stock Fund | 190,941 | 0.28% | $5.17M | 0.10% | Jun 30, 2026 |
| Fidelity Advisor Health Care Fund | 160,000 | 0.23% | $4.06M | 0.13% | Jul 31, 2026 |
| Emerald Growth Fund | 155,348 | 0.22% | $3.89M | 0.28% | Apr 30, 2026 |
| Fidelity Small Cap Index Fund | 144,686 | 0.21% | $3.67M | 0.01% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Yuling Luo | Chief Executive Officer, Director | 5,888,675 | 8.49% | Apr 20, 2026 |
| Shiping Chen | Chief Operating Officer, Director | 1,445,770 | 2.08% | Apr 20, 2026 |
| John L. Brottem | General Counsel | 29,000 | 0.04% | Sep 16, 2026 |
| Timothy Ogden White | President | 491,803 | 0.71% | Apr 20, 2026 |
| Justin J. McAnear | Chief Financial Officer | 37,220 | 0.05% | Apr 20, 2026 |
| Robert P. Ragusa | Director | 5,686 | 0.01% | Sep 3, 2026 |
| Rebecca Chambers | Director | – | – | Apr 20, 2026 |
| Frank Witney | Director | – | – | Apr 20, 2026 |
| Ian W. Ratcliffe | Director | – | – | Apr 16, 2026 |
| Qiming GP VIII, LLC | 10% owner | – | – | Nov 13, 2026 |
| Qiming Venture Partners VI, L.P. | 10% owner | – | – | Nov 13, 2026 |
| Qiming Venture Partners VIII Investments, LLC | 10% owner | – | – | Nov 13, 2026 |
| Qiming GP VIII-HC, LLC | 10% owner | 185,163 | 0.27% | Nov 13, 2026 |
| Qiming Venture Partners VIII-HC, L.P. | 10% owner | – | – | Nov 13, 2026 |
| Qiming Corporate GP VI, Ltd. | 10% owner | 1,632,188 | 2.35% | Nov 13, 2026 |
| Qiming Managing Directors Fund VI, L.P. | 10% owner | – | – | Nov 13, 2026 |
| Nicholas Naclerio | 10% owner | 10,104,566 | 14.56% | Apr 20, 2026 |
| Illumina Innovation Fund II GP, L.L.C. | 10% owner | 507,076 | 0.73% | Apr 20, 2026 |
| Illumina Innovation Fund II, L.P. | 10% owner | – | – | Apr 20, 2026 |
| Illumina Innovation Fund III GP, L.L.C. | 10% owner | – | – | Apr 20, 2026 |
| Illumina Innovation Fund III, L.P. | 10% owner | – | – | Apr 20, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 11, 2026 | Sale | −582 | $30.63 | $17.83K | 1,632,188 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 11, 2026 | Sale | −17,584 | $29.34 | $515.91K | 1,632,770 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 11, 2026 | Sale | −486 | $30.63 | $14.89K | 1,363,301 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 11, 2026 | Sale | −14,687 | $29.34 | $430.92K | 1,363,787 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 11, 2026 | Sale | −2,084 | $30.63 | $63.83K | 5,842,775 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 11, 2026 | Sale | −62,944 | $29.34 | $1.85M | 5,844,859 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 11, 2026 | Sale | −56 | $30.63 | $1.72K | 157,217 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 11, 2026 | Sale | −1,694 | $29.34 | $49.70K | 157,273 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 3, 2026 | Sale | −20,196 | $29.89 | $603.66K | 1,650,354 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 3, 2026 | Sale | −16,870 | $29.89 | $504.24K | 1,378,474 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 3, 2026 | Sale | −72,301 | $29.89 | $2.16M | 5,907,803 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 3, 2026 | Sale | −1,946 | $29.89 | $58.17K | 158,967 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 2, 2026 | Sale | −36 | $30.63 | $1.10K | 1,670,550 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 2, 2026 | Sale | −7,935 | $29.84 | $236.78K | 1,670,586 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 2, 2026 | Sale | −30 | $30.63 | $919 | 1,395,344 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 2, 2026 | Sale | −6,628 | $29.84 | $197.78K | 1,395,374 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 2, 2026 | Sale | −131 | $30.63 | $4.01K | 5,980,104 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 2, 2026 | Sale | −28,404 | $29.84 | $847.58K | 5,980,235 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 2, 2026 | Sale | −3 | $30.63 | $92 | 160,913 |
| Qiming Corporate GP VI, Ltd. 10% owner | Nov 2, 2026 | Sale | −763 | $29.84 | $22.77K | 160,916 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −327 | $33.31 | $10.89K | 1,678,521 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −950 | $31.96 | $30.36K | 1,678,848 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −11,205 | $30.70 | $343.99K | 1,679,798 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −13,593 | $29.93 | $406.84K | 1,691,003 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −273 | $33.31 | $9.09K | 1,402,002 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −793 | $31.96 | $25.34K | 1,402,275 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −9,359 | $30.70 | $287.32K | 1,403,068 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −11,354 | $29.93 | $339.83K | 1,412,427 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −1,169 | $33.31 | $38.94K | 6,008,639 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −3,400 | $31.96 | $108.66K | 6,009,808 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −40,112 | $30.70 | $1.23M | 6,013,208 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −48,659 | $29.93 | $1.46M | 6,053,320 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −31 | $33.31 | $1.03K | 161,679 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −92 | $31.96 | $2.94K | 161,710 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −1,080 | $30.70 | $33.16K | 161,802 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 30, 2026 | Sale | −1,309 | $29.93 | $39.18K | 162,882 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 28, 2026 | Sale | −8,450 | $33.11 | $279.78K | 1,704,596 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 28, 2026 | Sale | −9,846 | $32.47 | $319.70K | 1,713,046 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 28, 2026 | Sale | −7,058 | $33.11 | $233.69K | 1,423,781 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 28, 2026 | Sale | −8,224 | $32.47 | $267.03K | 1,430,839 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 28, 2026 | Sale | −30,249 | $33.11 | $1.00M | 6,101,979 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 28, 2026 | Sale | −35,248 | $32.47 | $1.14M | 6,132,228 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 28, 2026 | Sale | −814 | $33.11 | $26.95K | 164,191 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 28, 2026 | Sale | −948 | $32.47 | $30.78K | 165,005 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −4,226 | $31.88 | $134.72K | 1,722,892 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −9,791 | $31.33 | $306.75K | 1,727,118 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −1,386 | $30.33 | $42.04K | 1,736,909 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −3,531 | $31.88 | $112.57K | 1,439,063 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −8,178 | $31.33 | $256.22K | 1,442,594 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −1,157 | $30.33 | $35.09K | 1,450,772 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −15,131 | $31.88 | $482.38K | 6,167,476 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −35,049 | $31.33 | $1.10M | 6,182,607 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −4,960 | $30.33 | $150.44K | 6,217,656 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −408 | $31.88 | $13.01K | 165,953 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −943 | $31.33 | $29.54K | 166,361 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 27, 2026 | Sale | −134 | $30.33 | $4.06K | 167,304 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 26, 2026 | Sale | −19 | $31.07 | $590 | 1,738,295 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 26, 2026 | Sale | −24,027 | $30.52 | $733.30K | 1,738,314 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 26, 2026 | Sale | −16 | $31.07 | $497 | 1,451,929 |
| Qiming Corporate GP VI, Ltd. 10% owner | Oct 26, 2026 | Sale | −20,069 | $30.52 | $612.51K | 1,451,945 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 7 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Alamar Biosciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 97,025 shares on Oct 13, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Qiming Venture Partners VIII-HC, L.P. Affiliate | Oct 14, 2026 | 435,468 | $10.24M | Oct 14, 2026 | Private investment in series C preferred shares; automatically converted into common stock upon IPO |
| Qiming Venture Partners VIII Investments, LLC Affiliate | Oct 14, 2026 | 363,729 | $8.56M | Oct 14, 2026 | Private investment in Series C preferred shares, automatically converted into common stock upon IPO |
| Qiming Managing Directors Fund VI, L.P. Affiliate | Oct 14, 2026 | 41,945 | $987.00K | Oct 14, 2026 | Private investment in Series A-3 preferred shares, automatically converted into common stock upon IPO |
| Qiming Venture Partners VI, L.P. Affiliate | Oct 14, 2026 | 1,558,858 | $36.66M | Oct 14, 2026 | Private investment in Series A-3 preferred shares, automatically converted into common stock upon IPO |
See a number that looks wrong?